Dupont Capital Management’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
BC
RC
BFA
SAM
BIT
SFM
Dupont Capital Management's ANGO Position: Q3 2016 in Review
Dupont Capital Management sold out of AngioDynamics (ANGO) in Q3 2016, closing a stake of 53,032 shares — an estimated $762K sold.
Dupont Capital Management first reported a position in ANGO in Q4 2014 and held it in 5 quarters. The position peaked at $1.22M in Q1 2016. 130 funds tracked by Wall St. Rank hold ANGO as of Q3 2016.
- Dupont Capital Management reported no remaining AngioDynamics position as of Q3 2016 after selling out during the quarter.
- Dupont Capital Management sold 53,032 AngioDynamics shares in Q3 2016, an estimated $762K.
- Dupont Capital Management first reported a position in AngioDynamics in Q4 2014 and held it in 5 quarters.
- Dupont Capital Management's AngioDynamics position peaked at $1.22M in Q1 2016.
- 130 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2016.
Based on Dupont Capital Management's 13F filing for Q3 2016, filed 1 Nov 2016.